Background COH04S1, a synthetic attenuated modified vaccinia virus Ankara vector co-expressing
SARS-CoV-2 spike and nucleocapsid antigens, was tested for safety and …

TGF-β type III receptor (TβRIII) is a co-receptor for TGFβ family members required for high-affinity
binding of these ligands to their receptors, potentiating their cellular functions. TGF-βs, …

In the current post-pandemic era, recipients of an allogeneic hematopoietic stem cell transplant
(HCT) deserve special attention. In these vulnerable patients, vaccine effectiveness is …

The transforming growth factor receptor III (TβRIII) is commonly recognized as a co-receptor
that promotes the binding of TGFβ family ligands to type I and type II receptors. Within the …

Background By end December of 2021, COVID-19 has infected around 276 million individuals
and caused over 5 million deaths worldwide. Infection results in dysregulated systemic …

The rapid spread of COVID-19 on all continents and the mortality induced by SARS-CoV-2
virus, the cause of the pandemic coronavirus disease 2019 (COVID-19) has motivated an …

Background Although the mpox global health emergency caused by mpox virus (MPXV)
clade IIb.1 has ended, mpox cases are still reported due to low vaccination coverage and …

Cell-mediated immunity may contribute to providing protection against SARS-CoV-2 and its
variants of concern (VOC). We developed COH04S1, a synthetic multiantigen modified …

Hematopoietic cell transplantation (HCT) and chimeric antigen receptor (CAR)-T cell patients
are immunocompromised, remain at high risk following SARS-CoV-2 infection, and are …

To the Editor: Immunocompromised recipients of allogeneic hematopoietic stem cell transplant
(HCT) are at increased risk of severe COVID-19. 1 During the first year of a successful …